Loading
Life sciences · Journal article
Obesity Reviews · September 2, 2026
Raises a question worth testing. It does not answer one.
This is a narrative review that synthesizes mechanistic and preclinical evidence linking microbiome, metabolomics, and dietary patterns to obesity and metabolic control across the lifespan. The authors emphasize that causal mediation in humans remains unproven and identify AI/ML integration and longitudinal cohorts as priorities for precision nutrition, but do not report original empirical results or clinical outcomes.
Narrative review. Individuals across the lifespan from birth to older age; review scope, not a specific enrolled cohort.
Plant-based, fiber-rich dietary patterns enrich saccharolytic guilds and boost SCFA production Westernized dietary patterns favor bile-tolerant, amino acid-fermenting consortia and proinflammatory metabolites Preclinical data suggest incretin-based (GLP-1) therapies remodel the microbiome-metabolome axis
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
Clinicians should recognize that while diet-microbiome-metabolome links are mechanistically plausible and supported by preclinical work, human causal evidence is incomplete. The review advocates for precision nutrition approaches but emphasizes that actionable microbial and metabolomic signatures for individual responder prediction require further longitudinal and AI-integrated research.
This is a narrative review synthesizing mechanistic evidence and preclinical data on diet-microbiome-metabolome pathways in obesity, without reporting primary empirical results, clinical trials, or causal proof in humans.
As stated by the source record.
Clinicians should recognize that while diet-microbiome-metabolome links are mechanistically plausible and supported by preclinical work, human causal evidence is incomplete. The review advocates for precision nutrition approaches but emphasizes that actionable microbial and metabolomic signatures for individual responder prediction require further longitudinal and AI-integrated research.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Obesity arises from intertwined and reciprocal diet-microbiome-host pathways that reshape energy balance, insulin sensitivity, and inflammation. This review synthesizes mechanistic links between microbial functions and metabolic control, charts lifestyle-related lifecourse dynamics from birth to older age, examines how GLP-1-based therapies may perturb gut ecology and metabolite output and surveys AI/ML frameworks for multi-omics integration. Plant-based, fiber-rich dietary patterns generally enrich saccharolytic guilds, boost SCFAs production, and modulate bile acid signaling, whereas Westernized patterns favor bile-tolerant, amino acid-fermenting consortia and proinflammatory metabolites. Preclinical data suggest that incretin-based therapies remodel the microbiome-metabolome axis, but human causal mediation remains unproven and observed changes may partly reflect weight loss or metabolic improvement. Function-centered metrics outperform phylum-level ratios for translation. Harmonized longitudinal cohorts and explainable ML-derived microbial and metabolomic signatures are now pivotal to identify responder subtypes and actionable microbe-metabolite targets, enabling precision nutrition alongside pharmacotherapy across the lifespan.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.